Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “gonadotropin”

38 pharma patents match "gonadotropin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 38
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 38 pharmaceutical patents matching "gonadotropin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

38 results for “gonadotropin” · 30,257 patents in full index Clear search

  1. US 12343321

    Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance

    China Agricultural University · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted

  2. US 11713324

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted

  3. US 11654182

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted May 23, 2023 · Expires May 18, 2043

    granted

  4. US 11530239

    Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

    The Board of Regents of the University of Oklahoma · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  5. US 10975124

    Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

    The Board of Regents of the University of Oklahoma · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  6. US 10941159

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  7. US 10864254

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  8. US 10336769

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  9. US 10322167

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  10. US 9808510

    Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract

    Rani Therapeutics, LLC · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  11. US 9422310

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  12. US 8952161

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  13. US 8507536

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  14. US 8481738

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  15. US 8263588

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  16. US 8084614

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  17. US 7687610

    Human chorionic gonadotropin superagonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  18. US 7462625

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  19. US 7419983

    Gonadotropin-releasing hormone receptor antagonists and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  20. US 7329669

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  21. US 7229995

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted

  22. US 7179815

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted

  23. US 7176211

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 13, 2007 · Expires Feb 8, 2027

    granted

  24. US 7081459

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 25, 2006 · Expires Jul 20, 2026

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.